(YI) 111, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(YI) 111, Inc. Complete Analysis Pack
See the Bigger Picture
This 111, Inc. 4P's Marketing Mix Analysis explains the company’s Product, Price, Place, and Promotion in a concise, actionable format to support marketing research and strategy. The page shows a real preview/sample of the analysis so you can review style and content before buying; purchase the full version to get the complete ready-to-use report.
Product
Prescription medicines
111, Inc. sells prescription medicines through its B2C and pharmacy channels, making drugs a core part of its online-to-offline healthcare model. The offer links online consultation with e-prescription fulfillment, so patients can move from diagnosis to delivery in one flow. In its latest reported results, 111, Inc. kept this model centered on digital pharmacy access and local fulfillment.
OTC and Chinese medicines
In 2025, 111, Inc.’s OTC and Chinese medicine catalog covered both Western self-care drugs and traditional Chinese medicines, widening its reach into daily health needs. This mix supports routine purchases like cold relief, pain care, and digestion, plus repeat pharmacy demand. It also helps 111, Inc. serve users who want one stop for both modern and traditional care.
Vitamins and dietary supplements
111, Inc. sells vitamins and dietary supplements that meet preventive-health and wellness demand. The U.S. dietary supplement market was about $67 billion in 2023, showing why these items can add steady traffic. They also raise basket size beyond medicines, since shoppers often add them to routine pharmacy orders.
Medical supplies and devices
111, Inc.’s medical supplies and devices line covers contact lenses, bandages, thermometers, and other everyday care items, so it fits daily-health use and repeat buying. These low-ticket essentials help widen basket size and support broad consumer demand across home care and basic self-management.
- Daily-use healthcare items
- Broad, repeat consumer demand
- Supports everyday-health positioning
Personal care and infant care
111, Inc.’s personal care and infant care range adds skincare, birth control, sexual wellness, and baby essentials, so the platform covers more daily health spend. That broad mix supports cross-category baskets and repeat buying, and it helps turn 111, Inc. from a pharmacy-led channel into a wider household health destination.
- Skincare and infant care lift basket size.
- Birth control and wellness drive repeat demand.
- Broader mix improves cross-sell opportunities.
111, Inc.’s Broad Product Mix Drives Repeat Pharmacy Visits
111, Inc.’s Product mix centers on prescription drugs, OTC and Chinese medicine, supplements, and daily care items, so it covers both treatment and repeat self-care. That broad basket supports cross-sell and keeps pharmacy traffic tied to everyday health needs, not just one-off prescriptions.
| Product group | Role |
|---|---|
| Rx, OTC, Chinese medicine | Core pharmacy demand |
| Supplements, devices, care items | Repeat basket growth |
What is included in the product
Detailed Word Document
A concise, company-specific 4P analysis of 111, Inc.’s Product, Price, Place, and Promotion strategy, grounded in real market practice.
Editable Excel File
Condenses 111, Inc.’s 4Ps into a quick, easy-to-scan view that saves time and speeds alignment.
Reference Sources
Lists primary, reputable sources (industry reports, government data, benchmarks) to speed due diligence and let stakeholders verify key claims quickly.
Place
Online retail channels
111, Inc. uses online retail channels as the front door to its O2O model, linking digital traffic to fast fulfillment across China. Its platform reached 159.1 million prescription and OTC product orders in 2024, showing how scale comes from online access. The channel helps make healthcare products easier to buy, faster to ship, and available beyond major city stores.
B2B and B2C channels
111, Inc.'s dual B2B/B2C model lets it sell directly to consumers while also serving pharmacy and industry partners, so it can capture demand across both end markets. In its latest filings, the company showed scale in both channels through online traffic and partner-led distribution, which helps spread revenue risk. That mix widens reach and supports repeat sales.
Wholesale and retail pharmacy networks
111, Inc. uses wholesale and retail pharmacy networks to move products beyond its online platform, adding offline reach and faster last-mile access. This model improves availability, since orders can be filled through local pharmacy channels when direct online shipment is slower or less flexible. It also supports broader service coverage across China’s fragmented pharmacy market, where physical pharmacy density remains a key fulfillment edge.
14 Yi Hao Pharmacy stores
111, Inc. reported 14 Yi Hao Pharmacy stores in key cities such as Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. This gives the Company a real offline footprint for local trust, pickup, and last-mile service, while supporting its omni-channel reach in China.
- 14 retail pharmacies reported
- Presence in 5 major Chinese cities
- Supports local customer access
- Strengthens physical market coverage
Warehousing and logistics
111, Inc. runs warehousing and logistics as core back-end work, so inventory stays visible and healthcare orders move fast. These functions matter most in regulated pharma supply, where same-day pick, pack, and delivery can shape fill rates and service quality.
Supports inventory control
Helps on-time delivery
Drives healthcare fulfillment
111’s Omnichannel Scale: 159.1M Orders, 14 Stores
Place for 111, Inc. is an omnichannel network: online orders, partner pharmacies, and a small owned store base. In 2024, the platform handled 159.1 million prescription and OTC orders, while 14 Yi Hao Pharmacy stores in 5 cities added local access and pickup. Warehousing and logistics keep fill rates and delivery speed high.
| Place lever | Latest data |
|---|---|
| Online orders | 159.1 million in 2024 |
| Retail stores | 14 stores in 5 cities |
Get Your Copy
111, Inc. Reference Sources
The preview shown here is the actual 111, Inc. 4P's Marketing Mix Analysis you’ll receive instantly after purchase—no surprises; it covers Product, Price, Place, and Promotion with actionable insights and data-driven recommendations.
Promotion
Online consultation
111, Inc. uses online consultation to promote its services by linking users to healthcare guidance and product access in one flow. This makes the platform more than a sales tool; it works as a service-led healthcare channel. It also helps turn patient needs into faster orders and repeat use.
E-prescription fulfillment
111, Inc. uses e-prescription fulfillment as a direct bridge from medical advice to purchase completion, so the customer can move from diagnosis to checkout with less friction. That matters in China’s digital health market, where speed and accuracy shape repeat use. It also supports compliance, since the prescription is verified before the order is filled.
B2B marketplace
111, Inc.'s B2B marketplace lets third-party vendors sell directly to pharmacies, widening product reach across the supply chain and making the platform easier to find for buyers and sellers. By centralizing procurement, it supports faster order matching and tighter partner ties. As of the latest public filings available to me, 111, Inc. still uses this model to deepen pharmacy network engagement.
1 Pharmacy partner services
111, Inc. uses pharmacy partner services to lock in 1 Pharmacy clients by combining online loan applications with data and supply chain integration. That matters because pharmacies and wholesalers get faster working-capital access plus smoother ordering and inventory flow. This lowers friction and makes partners less likely to switch.
- Online loan applications support client cash flow
- Data links improve order visibility
- Supply chain integration raises partner stickiness
Yi Hao Pharmacy brand presence
Yi Hao Pharmacy gives 111, Inc. offline reach across multiple cities, so the brand is visible where healthcare trust matters most. Physical stores help turn online traffic into repeat buying and support the company’s O2O model. Each outlet works as a local trust point for prescription and OTC sales.
- Offline visibility in multiple cities
- Boosts healthcare trust and awareness
- Supports O2O conversion and repeat use
111, Inc. Drives Sales Through Care, Trust, and O2O Conversion
111, Inc. promotes itself through care-linked sales: online consults, e-prescriptions, and B2B procurement all push users from advice to order. Its pharmacy partner tools and Yi Hao Pharmacy stores extend reach, boost trust, and support repeat use across online and offline touchpoints.
| Channel | Role | Effect |
|---|---|---|
| Promotion | O2O, B2B, partner finance | More trust, faster conversion |
Price
No public price list disclosed
111, Inc. does not disclose a single public price list, so pricing is not transparent at the company-wide level. In practice, prices likely shift by product, channel, and partner terms, which is common in China’s digital healthcare and B2B supply chain model. That makes direct price benchmarking harder for investors and customers.
B2C retail pricing
111, Inc. uses item-level B2C retail pricing, so each SKU can move with local demand, promo depth, and category mix. This fits an online healthcare catalog that spans many product lines, from OTC to wellness. The model works best when price changes are small and fast, not one-size-fits-all.
B2B wholesale pricing
111, Inc. uses B2B wholesale pricing because it sells to pharmacies, wholesalers, and other partners in bulk, not at retail. This fits healthcare supply chains, where unit prices fall as order sizes rise. The model supports high-volume, repeat transactions and helps keep distribution costs per item lower.
Channel-based pricing
111, Inc. uses channel-based pricing because its online and offline routes serve different buyers and carry different delivery and service costs. In 2025, that split helps it price products by channel and by product type, so margins better match each channel’s cost to serve. It also lets 111, Inc. keep pharmacy and healthcare buyers aligned with order size, frequency, and fulfillment needs.
- Online and offline need different prices
- Pricing tracks channel cost differences
- Product type also affects price
- 2025 mix supports segment fit
Partner financing support
111, Inc. supports 1 Pharmacy clients with online loan applications, so the price lever here is business affordability, not consumer shelf price. This can ease inventory buys and reduce cash flow strain, especially when pharmacies must fund stock before sales come in.
- Improves access to working capital
- Helps smooth inventory purchases
- Lowers short-term cash pressure
111, Inc.’s 2025 Pricing Mix Balances Demand, Costs, and Cash Flow
111, Inc.’s price mix is split into 3 layers: B2C SKU pricing, B2B wholesale pricing, and channel-based pricing. In 2025, that setup let price move with demand, order size, and service cost, while the 1 Pharmacy loan offer eased pharmacy cash flow and supported inventory buys.
| Price lever | 2025 role |
|---|---|
| B2C retail | SKU-level demand pricing |
| B2B wholesale | Bulk order discounts |
| Channel pricing | Online/offline cost fit |
| 1 Pharmacy loans | Supports buy-now cash flow |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.